Atossa Therapeutics, Inc. Share Price
NASDAQ: ATOS | Micro Cap$2.18
+$2.18 (--%) Last updated on 31 Oct, 2026 | 01:15 ISTAtossa Therapeutics, Inc. Stock Performance
Atossa Therapeutics, Inc. Share Price Chart
$2.17$2.22
L
H
Atossa Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Atossa Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Atossa Therapeutics, Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Atossa Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.04 | $2.18 | +11.22% |
Sep 2026 | $2.44 | $1.96 | -25.19% |
Aug 2026 | $2.14 | $2.62 | +27.80% |
Jul 2026 | $1.94 | $2.05 | +5.94% |
Jun 2026 | $5.17 | $1.94 | -62.61% |
May 2026 | $5.87 | $5.17 | -4.70% |
Apr 2026 | $5.25 | $5.43 | +7.21% |
Mar 2026 | $4.30 | $5.07 | +16.17% |
Feb 2026 | $6.93 | $4.36 | +673.05% |
Jan 2026 | $0.60 | $0.56 | -3.42% |
Dec 2025 | $0.77 | $0.58 | -24.94% |
Nov 2025 | $0.89 | $0.78 | -12.39% |